RETINOBLASTOMA (RB) is the most common primary intraocular malignancy of infancy and childhood
The incidence of RB : 1 : 14000 -20000 LIVE BIRTHS
SPORADICALLY OR INHERITED
Mutation of the RB1gene, the q14band of chromosome 13
RB
: present with advance diseases in developing countries Eye enlargement is a common finding
Onset : first year of life in bilateral and family history, between 1 and 3 in sporadic unilateral cases
Early detection to maximize the visual outcome The quality of life of the affected child
Dilated pupil
o
o o o o o
Screening for RB should be part of well baby screening for new borns during the first three
months of life
The red reflex The corneal red reflex / Hirshberg test Eye examination
Can help define the structure abnormalities & reveal any calcium deposit
USG
o o
BLOOD TEST
The large white mass with prominent feeder vessels is located at the macula A smaller tumor is located in the inferolateral part of the retina.
A I II III IV V
Solitary tumor <4 DD Multiple tumors, none >4 DD Solitary tumor, 4-10 DD Multiple tumors, 4-10 DD Any lesion anterior to equator Solitary tumor > 10 DD Multiple tumors, some > 10 DD Any lesion anterior OS Tumor involving 50% of retina Vitreous seeding
15
International Classification
Group A Characteristics Small tumors, 3 mm, 3 mm from foveola, 1.5 mm from disc
B
C
Tumor > 3 mm, subretinal fluid < 3 mm from the base of tumor
Vitreous seeding (C1) 3 mm,or subretinal seeding (C2) 3 mm from tumor, or both (C3)
Vitreous seeding (D1) > 3 mm, or subretinal seeding (D2) > 3 mm from tumor, or both (D3)
E No visual potential, poor prognosis, tumor in anterior segment/ cilliary body/ iris neovascularization/ neovascular glaucoma/ vitreous hemorrhage/ phthisis bulbi/ tumor necrosis/ orbital cellulitis-like presentation/ optic nerve/ extraocular tumor
16
Cataract Congenital
Persistent hyperplastic primary vitreous (PHVP)
Coats Disease
Retinopathy of Prematurity (ROP)
Early Diagnosis
Prognosis
Survival rate nearly 95 % in last decade (USA)
TREATMENT
The
Vision Minimize
treatment
TREATMENT
Chemotherapy Cryotheraphy External
Beam Radiotheraphy
Enucleation
Enucleation
2nd & 3nd management RB Massive unilateral RB, Reese-Ellsworth group V or International clssification groups D&E Enucleationhigh risk histopatology chemotherapy reduce the risk of metastase
The combination of ectoposide phosphate, vincristine sulfate and carboplastine is infused every four week 6 month Indicated for children whose enucleated globes show features high risk metastasis
THAN K YOU